Bell Rock Capital LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 174 filers reported holding REVANCE THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bell Rock Capital LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$1,0000.0%1000.0%0.00%0.0%
Q3 2019$1,0000.0%1000.0%0.00%0.0%
Q2 2019$1,0000.0%1000.0%0.00%0.0%
Q1 2019$1,000
-50.0%
1000.0%0.00%0.0%
Q4 2018$2,0000.0%1000.0%0.00%0.0%
Q3 2018$2,000
-33.3%
1000.0%0.00%
-50.0%
Q2 2018$3,0000.0%1000.0%0.00%0.0%
Q1 2018$3,000
-25.0%
1000.0%0.00%0.0%
Q4 2017$4,000
+33.3%
1000.0%0.00%0.0%
Q3 2017$3,0000.0%1000.0%0.00%0.0%
Q2 2017$3,000
+50.0%
1000.0%0.00%0.0%
Q1 2017$2,0000.0%1000.0%0.00%0.0%
Q4 2016$2,0001000.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
NQ HCIF GP, Ltd. 3,096,650$42,114,000100.00%
Essex Woodlands Management, Inc. 4,592,047$62,452,00015.74%
DRILL CRAIG A 65,600$892,0001.76%
UNITED BANK 77,177$1,050,0001.04%
Iguana Healthcare Management, LLC 100,000$1,360,0000.55%
Rhenman & Partners Asset Management AB 220,000$2,992,0000.53%
ArrowMark Colorado Holdings LLC 1,669,992$22,712,0000.46%
Polar Capital LLP 1,168,542$15,891,0000.30%
Vivo Capital, LLC 77,373$1,052,0000.29%
SUFFOLK CAPITAL MANAGEMENT LLC 158,812$2,160,0000.28%
View complete list of REVANCE THERAPEUTICS INC shareholders